The genome of cowpea mosaic virus (CPMV), type member of the comovirus group of plant viruses, consists of two messenger-sense RNA molecules termed RNAs 1 and 2 (also known as B and M RNA, respectively) which are separately encapsidated in icosahedral capsid structures (for a review, see Goldbach & van Kammen, 1985) . The study of CPMV at the molecular level has been facilitated by the availability of genome-length cDNA copies of the RNAs that are linked to a RNA polymerase promoter sequence. These can be used to generate in vitro transcripts that are infectious when inoculated into protoplasts or onto whole plants (Vos et al., 1988; Eggen et al., 1989; Holness et al., 1989; Dessens& Lomonossoff, 1991) . In every case, however, the infectivity of the transcripts is significantly lower than that of natural virion RNAs, probably as a result of the presence of non-viral residues at the termini of the transcripts. Difficulties may also be caused by exposure of the transcripts to degradative agents during inoculation. For this reason the transcripts are usually stabilized by capping their 5' ends, but this is an inefficient, costly and time-consuming process.
Recently, the construction of directly infectious cDNA clones of brome mosaic virus RNAs 1, 2 and 3 (Mori et al., 1991) , beet necrotic yellow vein virus RNAs 3 and 4 (Commandeur et al., 1991) , pea early browning virus RNAs 1 and 2 (MacFarlane et al., 1992) , tomato mosaic virus RNA (Weber et al., 1992) and plum pox virus RNA (Maiss et al., 1992) have been reported. These constructs make use of the cauliflower mosaic virus (CaMV) 35S promoter sequence linked to the 5' ends of the viral cDNAs to generate infectious transcripts in the plant. This technique potentially overcomes some of the problems encountered with the use of transcripts generated in vitro. To test whether this approach is applicable to CPMV, clones containing full-length cDNAs of RNAs 1 and 2 downstream of the CaMV 35S promoter were constructed and tested for their ability to infect cowpea plants.
A modified CaMV 35S promoter sequence was excised from plasmid pCaP35J (Yamaya et al., 1988) with BamHI (filled in with Klenow polymerase after digestion) and PstI and was cloned into either HindIII-(filled in with Klenow polymerase after digestion)/PstI-digested M13mpl8 replicative form (RF) DNA or similarly treated pUC18 plasmid DNA, to give mp18-35S and pUC18-35S, respectively. By doing so, the positions of restriction sites flanking the promoter were changed so that no sites were left upstream of the promoter sequence and all the mpl8 cloning sites from PstI to EcoRI were present downstream (see Fig. 1 ). The promoter sequence contains a SstII restriction site at the 5' end and a StuI site at the 3' end. Digestion with the latter enzyme exposes the 3' end of the promoter sequence for direct blunt-end ligation of foreign sequences.
Full-length first strand cDNA to RNA2 was synthesized with Superscript reverse transcriptase (Gibco BRL) using pdT12_18 as a primer. Second strand synthesis was performed as described by Lomonossoff et al. (1982) using pd(TATTAAAATCTTAATAGG), corresponding to the first 18 nucleotides of RNA2. Full-length doublestranded DNA copies of CPMV RNA1 were synthesized as described in Dessens& Lomonossoff (1991). The full-length cDNAs were digested with either BamHI (position 1505 of RNA2; van Wezenbeek et al., 1983) or SstI (position 2301 of RNA1 ; Lomonossoff & Shanks, 1983 ) and the 5' end fragments were cloned into StuI/BamHI-digested or StuI/SstI-digested mp18-35S, to give mp18M-35S and mp18B-35S, respectively (for details of the cloning strategy, see Fig. 1 confirmed by sequence analysis of single-stranded M13 DNA (data not shown). RF DNA from mp18M-35S and mp18B-35S was digested with SstII and either BgIII (position 190 of RNA2) or PstI (position 351 of RNA1) and the 515bp SstII/BglII and 676bp SstII/PstI fragments (containing the 35S promoter sequence plus 5' ends of the cDNAs) were isolated. The rest of the RNA2 sequence was excised from pMT7-601, a derivative of pPMM2902 (Holness et at., 1989) in which the Escherichia coli promoter is replaced with a T7 promoter (Rohll et al., 1993) , with BglII and EcoRI (downstream of the RNA2 sequence; see Fig. 1 ), and the 3298 bp BgtII/EcoRIfragment was isolated. The rest of the RNA1 sequence was excised from pBT7-123 (Dessens & Lomonossoff, 1991) with PstI and EcoRI (partial digest since an EcoRI is also present downstream of the RNA1 sequence; see Fig. 1 ) and a 5569 bp PstI/EcoRI fragment was isolated. Subsequently, the two fragments containing RNA2 sequences and the two fragments containing RNA1 sequences were cloned into SstII/EcoRI-digested pUC18-35S by three-point ligations, to give clones pCP2 and pCP1, respectively. Thus, these clones contained the genome-length viral sequences downstream of the CaMV 35S promoter in pUC18 (Fig. 1) . Transcripts derived from these clones in the plant should have no non-viral nucleotides at their 5' ends, in contrast to in vitro transcripts derived from pBT7-123 and pMT7-601 which have a single non-viral G residue as their first nucleotide.
To investigate whether a combination of pCP1 and pCP2 DNA can infect cowpea plants, DNA was purified by centrifugation through ethidium bromide/caesium chloride gradients and was linearized with MluI and EcoRI, respectively. Inoculation of 10-day-old cowpea (Vigna unguiculata L.) seedlings was carried out by dusting the primary leaves with carborundum powder followed by manually abrading with 50 gl aliquots of an inoculum consisting of a mixture of various amounts of linearized pCP1 and pCP2 DNA dissolved in water. One leaf per plant was inoculated and the plants were maintained in the greenhouse at 25 °C. When the inoculum consisted of 10 gg of each of the linearized plasmids all four inoculated plants developed symptoms by 3 weeks post-inoculation. The symptoms were typical of a CPMV infection, consisting of chlorotic lesions on the inoculated leaves and systemic mosaic on the upper leaves. When smaller amounts of DNA were applied (5 or 2 lag of each plasmid) only one in four plants developed symptoms in each case. To verify that the symptoms noted above were due to infection of the plants with CPMV, total nucleic acid was isolated from the plants 3 weeks post-inoculation using the method of Verwoerd et al. (1989) . The RNA was fractionated on formaldehyde/MOPS-containing agarose gels (Lehrach et al., 1977) , transferred to a Hybond-N membrane (Amersham) and subjected to Northern blot analysis using 3~P-tabelled probes prepared according to the method of Feinberg & Vogelstein (1984) . The RNA2-specific probe consisted of nucleotides 482 to 2211 of RNA2 and the RNA1-specific probe consisted of nucleotides 2301 to 3858 of RNA1. The Northern blot analysis revealed that all the leaves which had been inoculated with 10 lag each of pCP1 and pCP2 contained CPMV RNAs 1 and 2 (Fig.  2) . When the inoculum consisted of only 5 lag of each plasmid, only those leaves which developed symptoms (one in four) revealed the presence of the CPMV-specific RNAs. The same was true of leaves inoculated with 2 lag of each plasmid (data not shown). Indeed, throughout this work the development of symptoms was found to be an entirely reliable guide to the occurrence of an infection. The level of CPMV-specific RNA found in extracts from leaves infected with pCP1 and pCP2 was similar to that found in leaves which had been infected with a mixture of 5 lag each of GpppG-capped transcripts derived from plasmids pBT7-123 and pMT7-601 (Fig. 2 , lane R). Inoculation of healthy cowpea plants with sap from a pCP1/pCP2-inoculated and infected plant resulted in infection (Fig. 2, lane S) , demonstrating that virus derived from pCP1 and pCP2 can be successfully passaged.
Leaf tissue was analysed for the presence of virus particles by the 'leaf-dip' method (Hitchborn & Hills, 1965) . CPMV-like particles, approximately 28 nm in diameter, were detected in the DNA-inoculated leaves (data not shown), demonstrating that the RNAs are encapsidated. The presence of visible lesions on the inoculated leaves and the appearance of mosaic symptoms on the upper leaves supported this notion since encapsidation is thought to be a prerequisite for both cell-to-cell and long distance movement of CPMV .
The constructs used in this study do not contain a polyadenylation signal downstream of the viral sequence, in contrast to the 35S-controlled clones constructed by Mori et al. (1991 ), Commandeur et al. (1991 , MacFarlane et al. (1992 ), Weber et al. (1992 and Maiss et al. (1992) . Instead, the clones used in this study are linearized downstream of the viral sequence, thus preventing the synthesis of transcripts longer than the genome. The sites used for linearization were identical to those used when making in vitro transcripts from pBT7-123 and pMT7-601 (Dessens& Lomonossoff, 1991; Rohll et al., 1993) . The RNA1 and RNA2 transcripts produced either in vitro or in the plant are therefore expected to have zero and seven non-viral nucleotides, respectively, downstream of the poly(A) tract. Inoculation with 10 lag of non-linearized D N A from each plasmid did not result in infection, judging from the lack of symptom formation (data not shown), confirming the importance of preventing the synthesis of over-size transcripts.
Efficient inoculation with the DNA constructs requires 10lag of each (ds) DNA per plant. For efficient inoculation with capped RNA transcripts, 5 lag of each RNA is used per plant, which is approximately equivalent to 5 lag of the transcribed plasmid DNA (Dessens& Lomonossoff, 1991) . Thus, the total amount of plasmid required for direct inoculation with DNA is about twice that required if transcripts are made first. However, since the direct use of DNA avoids all the problems and expense of carrying out in vitro transcription it still has a considerable advantage over the use of transcripts. Furthermore the clones may prove useful for transient expression studies in protoplasts. Hence the system reported here should facilitate the analysis of the CPMV replication cycle and contribute towards a more rapid understanding of the molecular biology of the virus.
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